Warning: fsockopen(): unable to connect to whois.arin.net:43 (Connection timed out) in /home/thinkbio/public_html/drugpatentwatch/blackhole/index.php on line 308

Warning: Cannot modify header information - headers already sent by (output started at /home/thinkbio/public_html/drugpatentwatch/blackhole/index.php:308) in /home/thinkbio/public_html/drugpatentwatch/inc/modules/general/header.php on line 57
Drugs covered by patent 8,557,852. Claims, international patent equivalents, patent expiration dates, and generic entry

Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

UBS
US Department of Justice
US Army
Healthtrust
Chubb
Argus Health

Generated: August 25, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,557,852

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,557,852 protect, and when does it expire?

Patent 8,557,852 protects BEVYXXA and is included in one NDA.

This patent has thirty-two patent family members in twenty countries.

Summary for Patent: 8,557,852
Title:Methods of using crystalline forms of a salt of a factor Xa inhibitor
Abstract: The present invention provides methods for preventing or treating a condition characterized by undesired thrombosis in a mammal using a crystalline polymorph form of a maleate salt of a compound of Formula I that has activity against mammalian factor Xa. ##STR00001##
Inventor(s): Grant; Craig (Burwell, GB), Kanter; James P. (San Ramon, CA), Langlands; Graeme (Soham, GB)
Assignee: Millennium Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:12/550,291
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 8,557,852

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Portola Pharms Inc BEVYXXA betrixaban CAPSULE;ORAL 208383-001 Jun 23, 2017 RX Yes No   Try a Free Trial   Try a Free Trial PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT)   Try a Free Trial
Portola Pharms Inc BEVYXXA betrixaban CAPSULE;ORAL 208383-001 Jun 23, 2017 RX Yes No   Try a Free Trial   Try a Free Trial PROPHYLAXIS OF VENOUS THROMBOSIS   Try a Free Trial
Portola Pharms Inc BEVYXXA betrixaban CAPSULE;ORAL 208383-002 Jun 23, 2017 RX Yes Yes   Try a Free Trial   Try a Free Trial PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT)   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Chinese Patent Office
Boehringer Ingelheim
Fish and Richardson
Federal Trade Commission
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.